Rising Innovation in Rare Diseases: PNH Market Set for Robust...

toegevoegd een audio Other

2026-03-04 05:52:43 - Translate

Rising Innovation in Rare Diseases: PNH Market Set for Robust Growth Through 2034

The global Paroxysmal Nocturnal Hemoglobinuria (PNH) market is entering a transformative era marked by innovation, expanding patient access, and sustained investment in rare disease therapeutics. Valued at US$ 3.8 Bn in 2023, the market is projected to grow at a CAGR of 10.8% from 2024 through 2034, ultimately reaching US$ 11.7 Bn by the end of the forecast period. This impressive growth is...

0 Reacties 0 aandelen 72 Views 0 voorbeeld